APA (7th ed.) Citation

PCT, H., AJ, S., JM, S., F, P., J, G., S, G., . . . A, L. (2026). The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: A randomised placebo-controlled trial. Psychopharmacology, 243(4), 819. https://doi.org/10.1007/s00213-025-06884-x

Chicago Style (17th ed.) Citation

PCT, Hawkins, et al. "The GPR139 Agonist TAK-041 Produces Time-dependent Alterations to Cerebral Blood Flow and Reward System Function in Patients with Schizophrenia: A Randomised Placebo-controlled Trial." Psychopharmacology 243, no. 4 (2026): 819. https://doi.org/10.1007/s00213-025-06884-x.

MLA (9th ed.) Citation

PCT, Hawkins, et al. "The GPR139 Agonist TAK-041 Produces Time-dependent Alterations to Cerebral Blood Flow and Reward System Function in Patients with Schizophrenia: A Randomised Placebo-controlled Trial." Psychopharmacology, vol. 243, no. 4, 2026, p. 819, https://doi.org/10.1007/s00213-025-06884-x.